|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
none (not assigned)
|
|
gptkbp:CASNumber
|
gptkb:557795-19-4
|
|
gptkbp:clinicalTrialPhase
|
Phase II
|
|
gptkbp:developer
|
gptkb:Merck
|
|
gptkbp:drugClass
|
recombinant human growth hormone
ghrelin receptor agonist
|
|
gptkbp:hasChemicalStructure
|
C27H36N4O5S
|
|
gptkbp:hasInChIKey
|
QZJTYWZEBPJYTH-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C27H36N4O5S
|
|
gptkbp:hasSMILES
|
CC(C)CN(C)CCCN=C(N)NCC1=CC=CC=C1C(=O)NC2=CC=CC=C2S(=O)(=O)C
|
|
gptkbp:hasTherapeuticUse
|
treatment of growth hormone deficiency
treatment of osteoporosis
treatment of obesity
treatment of muscle wasting
|
|
gptkbp:hasUNII
|
QX8X9N6F2H
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
557795-19-4
|
|
gptkbp:isNotApprovedBy
|
gptkb:FDA
gptkb:EMA
|
|
gptkbp:legalStatus
|
investigational
|
|
gptkbp:molecularWeight
|
528.66 g/mol
|
|
gptkbp:name
|
gptkb:MK-677
|
|
gptkbp:PubChem_CID
|
159633
CHEMBL1231375
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:synonym
|
gptkb:Ibutamoren
|
|
gptkbp:bfsParent
|
gptkb:sunitinib
gptkb:DB01234
|
|
gptkbp:bfsLayer
|
7
|